Major Insider Purchase: Broadwood Partners, a 10% Owner and Director, Buys $12.2M in STAAR Surgical Stock
Summary
Broadwood Partners, a significant investor and director, has made substantial open market purchases totaling over $12.2 million in STAAR Surgical Co shares, signaling strong conviction following recent negative financial news.
Key Events
-
Significant Insider Purchase
Broadwood Partners, a 10% owner and director, acquired 670,213 shares of STAAR Surgical Co common stock through open market purchases totaling $12,266,545 between March 11 and March 13, 2026.
-
Vote of Confidence Post-Earnings
This substantial investment follows the company's recent 10-K filing on March 3, 2026, which reported a significant decline in net sales and a widened net loss, suggesting strong conviction from a key insider despite recent challenges.
-
Increased Ownership Stake
Following these transactions, Broadwood Partners' total holdings in STAAR Surgical Co have increased to 16,123,842 shares.
Analysis
This substantial open market purchase by Broadwood Partners, a 10% owner and director, represents a critical vote of confidence in STAAR Surgical Co. The over $12.2 million investment, which is a significant portion of the company's equity, comes just days after the company reported a substantial 23.7% drop in net sales and a widened net loss in its 10-K filing on March 3, 2026. This timing suggests that a key insider group sees compelling value in the stock despite recent poor financial performance, potentially indicating a belief in a strong turnaround or undervaluation. Investors should view this as a strong bullish signal from a well-informed party.
At the time of this filing, STAA was trading at $18.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $932.8M. The 52-week trading range was $14.69 to $30.81. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.